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Abstract
Unlike other monoamine neurotransmitters, the mechanism by which the brain’s histamine content is regulated remains
unclear. In mammals, vesicular monoamine transporters (VMATs) are expressed exclusively in neurons and mediate the
storage of histamine and other monoamines. We have studied the visual system of Drosophila melanogaster in which
histamine is the primary neurotransmitter released from photoreceptor cells. We report here that a novel mRNA splice
variant of Drosophila VMAT (DVMAT-B) is expressed not in neurons but rather in a small subset of glia in the lamina of the
fly’s optic lobe. Histamine contents are reduced by mutation of dVMAT, but can be partially restored by specifically
expressing DVMAT-B in glia. Our results suggest a novel role for a monoamine transporter in glia that may be relevant to
histamine homeostasis in other systems.
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Introduction
Histamine was first identified as a potential neuromodulator at
the turn of the last century, and is now known to regulate multiple
physiological processes in mammals as well as invertebrates [1–9].
For all other classical neurotransmitters, the transport proteins
responsible for neurotransmitter storage and recycling play a
critical role in regulating the amount of transmitter that is
available for signaling at the synapse [10,11]. Therefore, to
understand the mechanisms by which histaminergic signaling is
regulated, it will be critical to determine the transporters and
transport mechanisms by which histamine and its metabolites are
stored, released and recycled.
Both cell surface and vesicular transporters are required for
neurotransmitter release and recycling. All classical neurotrans-
mitters are synthesized in the cytoplasm and therefore must
undergo transport into the lumen of secretory vesicles for regulated
release. Vesicular neurotransmitter transporters for most known
neurotransmitters have been identified and include the vesicular
glutamate (VGLUT1, 2 and 3) [12], GABA/Inhibitory Amino
Acid (VGAT/VIAAT) [13], acetylcholine (VAChT) and mono-
amine transporters (VMAT1 and 2) [14]. In mammals, histamine
is transported into synaptic vesicles and secretory granules by the
neuronal isoform of VMAT, VMAT2 [15–18].
After exocytotic release from the nerve terminal, neurotrans-
mitters can be recycled via either direct or indirect routes, and
each requires a distinct set of cell-surface transporters [19]. The
plasma membrane transporters responsible for the specific, high
affinity uptake of dopamine (DAT), serotonin (SERT), and
noradrenalin (NET) are well-characterized and localize primarily
to presynaptic nerve terminals [20]. Their localization is consistent
with a role in directly recycling monoamines for immediate re-
release, through re-uptake. In contrast, glutamate is primarily
transported by the excitatory amino acid transporters (EAATS)
into glia rather than the nerve terminal [21–23]; it is metabolized
to glutamine in glia by the enzyme glutamine synthase [24].
Glutamine is exported from glia via efflux through system N
transporters and then transported into glutamatergic neurons by
system A [25,26].
Since histamine is a monoamine neurotransmitter, its re-uptake
might be expected to occur at presynaptic nerve terminals, as for
other monoamines [9]. However, to date, a histamine transporter
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has not been identified in neurons. Rather, in mammals, astrocytes
take on this role. For example, they take up radiolabeled
histamine, possibly via non-specific organic cation transporters
(OCTs), and express the enzymes responsible for histamine
metabolism [27–32]. In mammals it is possible that histamine,
unlike all other neurotransmitters, is not recycled, but is degraded,
presumably in astrocytes. Alternatively, histamine, like glutamate,
might be recycled via a relatively circuitous route that requires
transport and metabolism in glia followed by re-export to neurons.
The Drosophila visual system is a useful system in which to study
histamine release and recycling [9]. Histamine is the primary
neurotransmitter released from insect and other arthropod
photoreceptors [33–35], and many of the molecular elements
required for histaminergic neurotransmission have been identified
in the fly’s visual system [33,36–39]. As for mammals, histamine is
synthesized in Drosophila by histidine decarboxylase, which
localizes to the presynaptic site of histamine release, the
photoreceptor terminal [34]. However, unlike mammals, it is
unclear how histamine is transported into synaptic vesicles, since
the Drosophila orthologue of VMAT is absent from fly photore-
ceptors [40]. Neurotransmitter release is both tonic and graded at
photoreceptors [41] and in Drosophila occurs at a rate sufficiently
high to require active mechanisms for recovery [9,42]. Changes in
the amount of histamine release and, perhaps more importantly,
its removal from the synaptic cleft, are presumed to signal to
interneurons and their ascending visual pathways [9]. However, it
is still not known how histamine concentration in the synaptic cleft
is controlled, nor is it clear how changes in synaptic histamine
might affect the higher functions of the visual system.
Histamine is metabolized in Drosophila by the product of the
gene ebony [43], which conjugates histamine to b-alanine to
generate the metabolite b-alanyl-histamine, or carcinine [44,45].
The gene product of tan mediates the hydrolysis of carcinine, and
thereby the liberation of histamine [36]. Interestingly, Tan is
localized to photoreceptors, the site of histamine synthesis,
whereas ebony is expressed in the epithelial glia that surround the
photoreceptor terminals [37,45]. The reciprocal localization of
Tan and Ebony, to neurons and glia respectively, implies that at
least in Drosophila, histamine is recycled via a relatively complex
pathway that involves uptake into glia [9]. Recent genetic
experiments suggest that the gene inebriated (ine) might function as
a carcinine transporter to allow metabolized histamine to be
taken up by photoreceptor cells [46]. However, the transporters
required for histamine uptake into glia and the mechanism by
which carcinine is exported from glia are still not known.
Moreover, with the possible exceptions of the OCTs and
Inebriated, the transporters responsible for histamine uptake
and homeostasis in both mammals and invertebrates likewise
remain obscure.
To investigate the regulation of aminergic signaling in the fly,
we have previously identified the Drosophila orthologue of the
vesicular monoamine transporter (dVMAT) [40,47]. The dVMAT
gene expresses two splice variants (DVMAT-A and -B) that differ
at their extreme C-termini [47]. This domain is required to traffic
mammalian VMAT2 and VACHT to synaptic vesicles and other
types of secretory vesicles [48–54]. As for mammalian VMATs,
DVMAT-A is expressed in all aminergic neurons in the fly CNS
[15–17,40,47,55]. We show here that DVMAT-B is not expressed
in neurons, but rather in a subset of glia that are adjacent to the
retina and store histamine. Furthermore, the loss of DVMAT-B’s
function at this site reduces histamine storage. These data indicate
that, unlike other VMATs, DVMAT-B has a functional role in glia
rather than neurons, and that DVMAT-B helps to regulate
histamine in the fly’s visual system.
Results
The mRNA of dVMAT is alternatively processed to yield two
variants [47]. In dVMAT-B, the segment indicated in Figure 1A is
retained. In dVMAT-A, all of the splice sites are used and the
indicated segment is removed as an intron. To determine the
expression pattern of dVMAT-B mRNA in the adult brain, we
performed in situ hybridization experiments. To generate a cDNA
probe specific for dVMAT-B, we amplified the sequence retained in
dVMAT-B mRNA and removed from dVMAT-A (Figure 1A, ‘‘B in
situ probe’’). Using this probe we observed a narrow band of
labeling in the region just beneath the retina (Figure 1B and 1C).
These data are consistent with a previous report showing that a
probe common to both dVMAT-A+B labels a thin band below the
retina in addition to aminergic neurons in the central brain and
optic ganglia [56]. Based on this labeling pattern and proximity to
the glial marker Neurexin IV, it was suggested that dVMAT might
be expressed in the fenestrated glia [56].
To further elucidate the localization and function of DVMAT-
B, we generated an antiserum to the N-terminus domain shared by
DVMAT-A and -B, and two separate antibodies specific for the
DVMAT-B C-terminus (see Methods for additional details). To
demonstrate the specificity of our antibodies and to investigate the
relationship of DVMAT-A and/or -B to histamine storage, we
characterized a dVMAT mutant line. (A more complete phenotypic
analysis of the dVMAT mutant will be reported elsewhere.) We
have previously reported that CG6119 encodes the 39 portion of
dVMAT [47], and have obtained a line (l(2)SHO459) containing a
transposable P element in this predicted gene segment [57]. We
used inverse PCR and DNA sequencing to confirm that the
insertion site of l(2)SHO459 is in the last coding exon of dVMAT.
The insertion creates a functional deletion of the last two
transmembrane domains of both DVMAT-A and -B (see
Figure 1D, ‘‘P’’). We therefore refer to l(2)SHO459 as dVMATP1.
Western blots of adult head homogenates were probed with the
antibody directed to the N-terminus of DVMAT shared by the
DVMAT-A and -B splice variants (anti-N). Little or no protein
representing either DVMAT isoform remains in the homozygotes
containing the P insertion as compared with controls (Figure 1E,
compare lanes ‘‘P/CyO’’ and ‘‘P/P’’). The absence of a detectable
Author Summary
Neurons, the cells in the brain responsible for carrying
information, communicate with each other using a class of
chemicals known as neurotransmitters. One family of
neurotransmitters, the monoamines, includes dopamine,
serotonin, and histamine, all of which play major
physiological roles. However, unlike dopamine and sero-
tonin, the regulation of the brain’s histamine content is
poorly understood. We are using the fruitfly Drosophila
melanogaster to study the storage and release of histamine
from brain cells. Both mammals and insects use a class of
proteins called transporters to store amines, but, to date,
amine transporters have been thought to be restricted to
neurons. We have found that the support cells, or glia, that
facilitate the function of neurons in the fly’s visual system
contain a new form of monoamine transporter. Despite its
circumscribed distribution, this protein is required to
maintain normal levels of histamine throughout the visual
system. We speculate that other animals may use a similar
strategy to regulate the function of this important
neurotransmitter.
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band in homogenates derived from the dVMATP1 mutant
demonstrates that anti-N is specific for DVMAT.
To generate additional dVMAT alleles, we excised the P-element
in dVMATP1. One allele, dVMATD14, removes most of the
transposon including the white (w) eye marker gene but leaves
behind 51 base pairs within the sixth and last coding exon of
dVMAT. The insertion is in-frame and encodes an additional 17
amino acids (HDEITSSLLTLFHHELG). Immunoblots of
dVMATD14 flies using anti-N show very small amounts of DVMAT
(Figure 1E, ‘‘D14/D14’’).
We next characterized the two C-terminus directed antibodies
that we generated to specifically detect DVMAT-B. Since only the
C-termini of DVMAT-A and -B differ, a peptide representing the
last 21 amino acids of DVMAT-B was used to develop a
polyclonal antibody specific to the B form (anti-B1, see Methods).
Immunoblots using anti-B1 did not show a detectable band on
Western blots using adult head homogenates that gave robust
signals when probed with either anti-DVMAT-A or anti-N (not
shown). Therefore, to validate the specificity of the antibody and
to determine the expression pattern of the DVMAT-B splice
variant, we performed immunolabeling experiments using whole
adult brains. In contrast to our previously described antibody to
DVMAT-A (see [40,47]), aminergic neurons in the adult brain
were not labeled with anti-B1. Rather, anti-B1 specifically labeled a
relatively thin layer between the retina and the optic lobe
(Figure 2A). To confirm the specificity of labeling using anti-B1,
we repeated this experiment using the dVMATD14 flies. Labeling
using anti-B1 was dramatically reduced in the D14 mutants
(Figure 2B), confirming the specificity of the anti-B1 antibody.
Additional labeling experiments using anti-B1 indicate that
DVMAT-B is not expressed elsewhere in the adult fly brain (data
not shown). Despite the presence of dVMAT-B mRNA in the
embryonic nervous system [47] we did not detect DVMAT-B
protein in labeling experiments using anti-DVMAT-B in either
whole embryos, the central nervous system of third-instar larvae
(central brain plus optic lobes), or larval fillets that included Type
II neuromuscular junctions, which are octopamine positive [58].
A previous study has shown that an mRNA in situ probe for
dVMAT-A+B labels cells beneath the basement membrane that
correspond in position to those of fenestrated glia [56]. Our in situ
results and immunolabelings using anti-B1 confirm this pattern for
both the dVMAT-B mRNA and the DVMAT-B protein. We were
surprised by these results and the possibility that DVMAT-B
might—as a result—localize to glia, since mammalian VMATs
localize exclusively to neurons and neuroendocrine cells [15–
17,59]. We therefore performed additional experiments using a
second antibody that was independently generated against the C-
terminus of DVMAT-B (anti-B2.). We used anti-B2 to label
cryosections, and co-labeled with an antibody to Ebony to help
demonstrate the localization of the DVMAT-B label. Ebony labels
a defined subset of glia in the lamina and medulla (the epithelial
glia; [45]). Using anti-B2 we obtained results similar to those
obtained in experiments using anti-B1; we observed a single band
of labeling in wt flies that was absent in dVMATP1 flies (Figure 2C
and 2D) between the retina and the lamina, and absence of
labeling at other sites in the adult brain. These data confirm the
specificity of anti-B1 and -B2 and indicate that DVMAT-B protein
is expressed in a single relatively restricted region of the adult
brain, consistent with our in situ probe of dVMAT-B mRNA.
To determine the identity of the cells expressing DVMAT-B, we
first performed additional experiments using the anti-N antibody
directed against the N-terminus of DVMAT. Since the N-terminus
of DVMAT is common to both DVMAT-A and B, labeling using
anti-N showed the expression of both isoforms (DVMAT-A+B)
Figure 1. Mutant alleles of dVMAT reduce expression of
DVMAT-A and -B. (A) dVMAT-A and -B share a common translational
start site (indicated as ‘‘A, B start’’) and a common N-terminus, but
diverge at their C-termini. Coding exons in the dVMAT gene that are
common to both dVMAT-A and-B are shown as gray boxes, introns as
black lines. To generate alternative carboxy termini, the indicated
genomic sequence (magenta box) is spliced out from dVMAT-A and
retained in dVMAT-B. The in situ probe for dVMAT-B contains the first
260 nucleotides of this sequence. The P element insert in the dVMAT
mutant allele dVMATP1 (black arrowhead) disrupts the coding sequence
of both dVMAT-A and -B. (B,C) In situ hybridization of head sections
shows transcription of the dVMAT-B gene in a layer between the retina
and lamina (B). Magnified view of (B) shown in (C). (D) Cartoons
showing the predicted topology of DVMAT with lumenal domains
above and cytoplasmic domains below the parallel gray lines
representing the vesicle membrane. Open circles indicate domains
shared by DVMAT-A and -B. Filled, magenta circles indicate the C-
terminal domain specific for DVMAT-B. The P element insertion site in
the last exon of the dVMATP1 (marked with ‘‘P’’ and a black arrowhead)
functionally deletes transmembrane domains 11 and 12 and the C-
terminus (shaded gray). The imprecise excision allele dVMATD14 results
in an insertion of 51 base pairs, and 17 amino acids in-frame with the
original downstream codons (marked as ‘‘D14’’ with a blue arrowhead,
with blue circles indicating the inserted residues). (E) Western blot using
the N-terminus antibody directed against both DVMAT-A and -B splice
variants shows an absence of DVMAT protein in dVMATP1 homozygotes
(P/P), and dramatically reduced levels in dVMATD14 (D14/D14),
compared with heterozygous controls (P/CyO and D14/CyO). The
plasma membrane associated protein Late Bloomer (indicated as ‘‘lb’’)
was used as a loading control. Re, retina; La, lamina; Me, medulla. Bars:
(B) 50 microns, (C) 20 microns.
doi:10.1371/journal.pgen.1000245.g001
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and allowed the simultaneous visualization of both patterns of
expression. In Figure 3A, labeling with anti-N in whole-mounts of
the entire brain revealed a punctate pattern in the central brain
and medulla as well as scattered cell bodies. This pattern was
similar if not identical to the labeling in the adult brain we
previously observed using an antibody specific for DVMAT-A
[40]. Labeling with DVMAT-A also showed a punctate pattern in
the lamina that represents projections from the LP2 cluster of
serotonergic neurons [40]. Using anti-N to label DVMAT-A+B,
we observed a similar punctate labeling pattern in the lamina
(Figure 3A and 3B); however, unlike the pattern we saw using the
antibody to DVMAT-A, the entire surface of the lamina was
labeled by anti-N (Figure 3A, see also Figure 3C). These data are
consistent with the expression pattern of DVMAT-B in the distal
lamina that we observed using the anti-B antibodies.
The structure of the lamina has been analyzed in both the housefly
and Drosophila [60–64]. The region expressing DVMAT-B in the
distal lamina contains several layers of morphologically distinct glia.
To determine whether the cells in the lamina that express DVMAT-
B might indeed be glia, adult heads were fixed and sectioned using a
cryostat and then double-labeled with the primary antibodies anti-N
(Figure 3D) and a glia-specific marker, anti-Repo (Figure 3E).
Labeling of cryostat sections with anti-N showed bands of punctate
labeling in the medulla, consistent with previous labelings using the
antibody to DVMAT-A [40]. Labeling with anti-N in the medulla
revealed that there was a minimal overlap with glial cell nuclei,
consistent with the exclusive localization of DVMAT-A to aminergic
neurons in the central nervous system [40,47]. In contrast, a band
just beneath the retina labeled with anti-N (Figure 3D, arrow)
appeared to overlap with Repo-labeled glial cell nuclei in the distal
lamina (Figure 3F), supporting the possibility that DVMAT-B is
indeed expressed in glia.
To further examine the localization of DVMAT-B, we
performed co-labeling experiments using the antibodies specific
for DVMAT-B: anti-B1 and anti-B2. To establish the relationship
of DVMAT-B labeling to photoreceptors, we first performed co-
labelings using an antibody to the gene product of tan. Although
originally identified as a mutation affecting pigmentation in the
cuticle [43], Tan protein also localizes to photoreceptors, where it
converts recycled carcinine to histamine [36,37,44]. Labeling with
anti-B2 (red) and anti-Tan (green) revealed a mutually exclusive
pattern of expression, indicating that DVMAT-B was not
expressed in photoreceptor cells (Figure 4A–4C). Rather, it
appeared to bracket the photoreceptor cell axons where they
extended beneath the retina, in a position beneath the basement
membrane. Co-labeling with anti-B1 and the photoreceptor
specific antibody MAb24B10 [65,66] confirmed this relationship
(data not shown).
We next used the DVMAT-B specific antibodies to directly
investigate the expression of DVMAT-B in glia. For these
experiments, we used the line repo-Gal4 to drive expression of
mCD8-GFP and thereby label the plasma membrane of glial cells
(Figure 4D–4I). This stratagem labeled glial cell membranes
throughout the optic lobe and central brain (Figure 4D and 4G).
Using the anti-B2 antibody we observed partial co-localization of
DVMAT-B to the profiles enclosed by these glial cell membranes
in the distal lamina (Figure 4F and 4I). As in the medulla, the glial
processes in the distal lamina that extended toward the retina were
less intensely labeled than other more proximal membranes
(Figure 4D–4F), as clearly seen at high magnification (Figure 4G–
4I). Nonetheless, these data strongly suggest that DVMAT-B is
expressed in a subset of glial membranes abutting the retina. In
addition, the localization and morphology of the DVMAT-B
expressing cells suggests that they correspond to the fenestrated
glia previously described in the housefly [62] (see Discussion).
Even though it has been suggested that dVMAT mRNA is
expressed in the fenestrated glia [56], the localization of a vesicular
monoamine transporter to glial cells had not been conclusively
demonstrated. Both because of the heterodox nature of our
observation and the difficulty inherent in interpreting co-
localization from light micrographs, we performed additional
immunolabelings at higher resolution, using electron microscopy
(EM). For these experiments we used the anti-N antibody to
visualize DVMAT-A+B; anti-N but not anti-B1 gave a good EM
signal using the pre-embedding method. A high concentration of
silver-enhanced gold particles was readily detected in the lamina,
proximal to the basement membrane (Figure 5A), with some
additional labeling seen in the retina itself. In addition, small
profiles in the lamina cortex were also labeled. These may be
profiles of serotonin-containing nerve terminals that express
DVMAT-A [40], and are consistent with the punctate lamina
labeling seen in light micrographs with anti-N (see Figure 3). The
labeled glia were penetrated by ommatidial bundles of photore-
ceptor axons and also had extensive convolutions of their proximal
cell surface (Figure 5B), consistent with the morphology of the
fenestrated glia [62]. The convoluted morphology of the glia
membranes made it difficult to determine the precise subcellular
localization of DVMAT in material prepared by the pre-
embedding method.
Previous electron microscopic analyses in the housefly have
shown that two layers of glia occupy the region immediately
beneath the basement membrane in the lamina. These include not
only the fenestrated glia immediately abutting the basement
Figure 2. Antibodies raised against the C-terminus of DVMAT-B
label the distal lamina. Confocal images of whole adult w and
dVMATD14 mutant brains were labeled with the DVMAT-B antiserum
anti-B1 (A,B). Labeling is visible in the distal lamina of the w control
brain (A), but markedly reduced in the homozygous dVMATD14 mutant
(B). Confocal images of wt and dVMATP1 homozygote head sections
were labeled with anti-B2 (C,D) (magenta) and anti-Ebony (C,D) (green).
In the wt, control sections, DVMAT-B labeling is visible in the distal
lamina (C). In the dVMATP1 mutant, however, no DVMAT-B expression is
detected (D). These results demonstrate the specificity of both anti-B1
and -B2. Re, retina; La, lamina; Me, medulla. Bars: 50 microns.
doi:10.1371/journal.pgen.1000245.g002
Glial Amine Transporter
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membrane but also the pseudocartridge glia, which are proximal,
i.e. closer to the central brain, relative to the fenestrated glia
[61,62]. Both are distal to the somata of the laminar cortex and, with
the exception of the photoreceptor axons that penetrate these glia,
neither the cell bodies nor processes of neurons occupy the region of
the distal lamina that is labeled by DVMAT-B. Thus, the immuno-
EM data support the conclusion that DVMAT-B is expressed in glial
cells. Furthermore, DVMAT labeling is close to the basement
membrane (Figure 5A and 5B), and additional label is seen in the
proximal retina, consistent with our light micrographs (Figures 3 and
4). We therefore conclude that DVMAT-B expressing cells represent
the fenestrated glia (see Discussion).
Previous immunohistochemical studies have shown that a
similar region in the distal lamina just beneath the basement
membrane is labeled with an antibody to histamine [44]. This
location suggests that histamine could be contained in the
fenestrated glia, but this interesting possibility has never been
addressed. Furthermore, the fact that DVMAT-B localizes to cells
in this region suggests that it might play a hitherto unacknowl-
edged role in the glial storage of histamine in the Drosophila visual
system. Importantly, the 12 transmembrane ‘‘backbone’’ required
for transmitter transport is equivalent in DVMAT-A and -B, and
we have shown that the DVMAT backbone common to DVMAT-
A and -B recognizes histamine [47].
To immunolabel histamine in the fly’s visual system, we used a
previously characterized antibody and fixation protocol [67].
Consistent with previous reports [35,44], the histamine antibody
immunolabeled the retina, nerve terminals in the medulla, and
much of the proximal lamina (Figure 6A). In addition, a band
immediately beneath the retina in the distal lamina (Figure 6A)
was labeled strongly for histamine. Strikingly, double labeling
using anti-B2 showed robust co-localization (Figure 6B and 6C),
suggesting that the same glial cells that express DVMAT-B also
store histamine.
To explore this possibility further, and examine the possible
functional role of DVMAT-B in histamine storage, we determined
whether loss of dVMAT would decrease histamine labeling. To test
this possibility, we used the same antibody against histamine to
label brains from the dVMATD14 mutant and from w controls, and
visualized the pattern of immunolabeling using confocal micros-
copy. In w optic lobes the antibody labeled the retina, distal
lamina, and axon terminals in the medulla (Figure 7A, 7C, and
7D). Removal of the retina prior to labeling allowed visualization
of the lamina surface and revealed a robust labeling pattern at the
distal surface of the lamina in the w control (Figure 7B) that was
dramatically reduced in the dVMATD14 homozygote (Figure 7E).
This difference suggested that not only do the subretinal cells that
express DVMAT-B store histamine, but also that DVMAT-B
function in these cells is required for histamine storage.
Since neither DVMAT-A nor DVMAT-B are expressed in
photoreceptor cells [40,47], we were surprised to find that histamine
labeling in photoreceptor cell bodies in the retina was also decreased
Figure 3. The antibody to DVMAT-A+B labels the optic neuropiles. (A) Projected confocal image of whole w adult brain labeled with the
antibody against the N-terminus of DVMAT (anti-N) that recognizes both DVMAT-A and -B. The entire surface of the lamina is labeled with anti-N in a
honeycomb pattern (white arrows). In the central brain, cell bodies (asterisk) and a large number of processes are labeled, consistent with the
previously described expression of DVMAT-A. Additional punctate labeling in the lamina (B) (arrowheads) is likely to represent previously described
serotonergic varicosities, more easily seen in a single optical section of the lamina (B) (arrowheads) and in a tangential section through the lamina (C)
(La, see arrowheads) and distal medulla (C) (Me). Labeling of the lamina surface is also apparent (C) (arrows) in the tangential view of the lamina and
distal medulla. (D–F) Cryostat sections of w adult brains labeled for Repo (green) and DVMAT-A+B (magenta). Repo label in glial cell nuclei of the optic
lobe and central brain does not co-localize with the label for DVMAT-A+B, but the DVMAT-A+B label in the distal lamina appears to co-localize with
glial cell nuclei (D) (arrow) (overlap shown in F). Bars: (A) 50 microns, (B,C) 25 microns, (D–F) 50 microns.
doi:10.1371/journal.pgen.1000245.g003
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in dVMATD14 relative to controls (compare Figure 7C and 7F,
arrowheads). In contrast, dVMAT mutants showed no dramatic
decrease in labeling for histamine in the proximal lamina near the
chiasm, or in photoreceptor cell terminals in the medulla (compare
Figure 7D and 7G). Thus, the presumptive role of DVMAT-B in
neurotransmitter storage does not extend to all aspects of histamine
homeostasis in the fly. Nonetheless, these data suggest that dVMAT
may regulate histamine storage and homeostasis in the visual system
in a more general fashion than might be expected based on its
circumscribed pattern of expression.
Cryostat sections labeled for histamine also showed decreased
labeling in the distal lamina and the retina in the dVMATD14
mutant (Figure 7I) relative to the w control (Figure 7H). The
labeled sections also show that the residual labeling in the
proximal lamina localizes to a region previously shown to contain
another glia subset, the marginal glia [62,68]. The pronounced
labeling of this region suggests that histamine might be
redistributed to an ectopic site in the dVMAT mutant.
To quantify the contribution of DVMAT to histamine storage
more accurately, we used high performance liquid chromatography
(HPLC) to measure the total histamine content in dVMAT mutant
heads (Figure 8A). As controls, we used: 1) w1118Cs10 (w; +/+), the
genetic background into which dVMATP1 had been out-crossed; 2) a
precise excision of the P element in l(2)SHO459 (p.e.); and 3)
dVMATP1 heterozygotes (P/+). The histamine content in heads
derived from the three control lines—w1118Cs10, p.e., and P/+—was
660.4, 5.960.4 and 6.160.3 and ng/head respectively. In contrast,
the dVMATP1 (P/P) homozygotes contained 4.260.2 ng/head, a
30% reduction relative to the controls (Bonferroni post-test, p,0.01).
The homozygous imprecise excision (dVMATD14, ‘‘D14’’ in
Figure 8A), contained 3.260.5 ng/head, a 47% reduction relative
to controls (Bonferroni post-test, p,0.001). These data indicate that
dVMAT plays an unexpectedly important role in regulating the
histamine content of the head, and together with the results from our
histamine labelings they indicate that this role is exerted on the visual
system by means of the fenestrated glia.
Finally, to address the role of DVMAT-B in the glial storage of
histamine more specifically, we performed genetic rescue exper-
iments (Figure 8B). To rescue the function of DVMAT-B in glia,
we used the repo-Gal4 driver to drive expression of the UAS-
dVMAT-B transgene. We compared the histamine concentrations
of heads from homozygous mutant flies containing repo-Gal4 alone
Figure 4. DVMAT-B is not detected in photoreceptor cells and co-localizes with a marker for Drosophila glia. A primary antibody to the
protein Tan (A) (green) labels the photoreceptor cell bodies and their axons that extend into the lamina (La) and medulla (Me), seen in horizontal
cryostat sections of the head. Co-labeling with anti-B2 (B) (magenta) shows no overlap with Tan in merged images (C). Glia were labeled using repo-
Gal4 to drive expression of the plasma membrane marker mCD8-GFP (D,G) (green). Some glial processes extend into the medulla (D,G) (small
arrowheads). DVMAT-B was co-labeled using anti-B2 (E,H) (magenta). The merged images (F,I) show robust co-localization of DVMAT-B to profiles
enclosed by glial cell membranes in the distal lamina, and additional, faint co-labeling of processes that extend distally into the retina (F,I) (large
arrowheads). (G–I) Enlarged views of (D–F), to show the co-localization of the two signals. Bars: (A–F) 50 microns, (G–I) 10 microns.
doi:10.1371/journal.pgen.1000245.g004
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versus repo-Gal4+UAS-dVMAT-B. We note that repo-Gal4 alone
decreased histamine levels (compare Figure 8A and 8B).
Therefore, all flies were tested in a repo-Gal4 background, and
our control for baseline histamine levels was dVMATP1/+; repo-
Gal4/+ (indicated as ‘‘Base.’’ with the genotype abbreviated as P/
+; Repo/+). The repo:dVMAT-B, genetically rescued flies (‘‘Res.1’’
and ‘‘Res.2’’), showed a significant increase (Dunnett’s multiple
comparison test, p,0.05) in histamine relative to those containing
repo-Gal4 alone (indicated as ‘‘Mut.’’ P/P, Repo/+). These data
indicate that expression of DVMAT-B in glia partially rescues the
loss of histamine from the visual system.
Discussion
As for glutamate, but unlike other biogenic amines, histamine
recycling in Drosophila requires metabolism in nearby glia.
Hitherto, the glial recycling pathway has been thought to be
restricted to the epithelial glia that surround sites of lamina
histamine release at the photoreceptor terminals [36,37,44,45].
We now find that DVMAT-B localizes to a separate subset of glia
that lie at the interface between the retina and the lamina, and that
loss of DVMAT-B reduces histamine storage in the visual system,
thus implicating these cells in the overall regulation of histamine
after its release from photoreceptors.
Ultrastructural and immunohistochemical studies in the fly have
identified several distinct glial populations in the lamina. Although
detailed ultrastructural accounts are available only in the housefly
[61,62], it is clear that Drosophila has similar populations of glia,
and that genetic markers exist for most [68,69]. The epithelial glia
have been assigned an important role in histamine recycling
[36,44,45], but the remaining glial subtypes have not been
functionally characterized. The fenestrated glia lie closest to the
retina and surround the photoreceptor axons as they enter the
distal face of lamina (see Figure 9A). Processes from the fenestrated
glia also extend through the basement membrane and into the
retina. Our data strongly suggest that DVMAT-B localizes to the
Drosophila equivalent of the fenestrated glia, consistent with the
previously described location of the dVMAT transcript [56].
We find that DVMAT-B expression in glia is important for
regulating the histamine content of the visual system. Mutation of
dVMAT decreases histamine storage in the fly’s head and expression
of DVMAT-B in glia partially rescues this deficit. Importantly,
immunolabeling for histamine in dVMAT mutants shows changes in
both the fenestrated glia and photoreceptor cells, suggesting a more
prominent role for DVMAT-B in histamine homeostasis than might
be expected based on its limited pattern of expression.
We have shown previously that histamine and other mono-
amines are recognized by a DVMAT/VMAT2 chimera contain-
ing the domains common to DVMAT-A and -B [47]. These data
Figure 5. Immuno-EM shows that DVMAT in the distal lamina
labels glia. (A) Electron micrograph of a tangential section through the
proximal retina (Re) with seven rhabdomeres (arrowheads) visible in
two complete cross-sections of ommatidia. The basement membrane,
bm arrows in (A,B), separates the retina from the underlying lamina.
Electron-dense gold particles lie just beneath the basement membrane.
Beneath this band of labeling, an additional small profile quite distinct
in appearance (double arrowhead) also expresses label, and may
represent the profile of a serotonin-containing nerve terminal. (B)
Higher magnification views of the labeled fenestrated glia and
photoreceptor axons in the distal lamina. Gold particles (arrowhead)
overlie the fenestrated glia. bm, basement membrane; pa, photorecep-
tor axons; t, tracheae; lc, glial nuclei. Bars: (A) 5 microns, (B) 2 microns.
doi:10.1371/journal.pgen.1000245.g005
Figure 6. Co-labeling for DVMAT-B and histamine. (A) A primary antibody to histamine (magenta) labels photoreceptor cell terminals in the
medulla (asterisks), an area in the proximal lamina (arrowheads) that contains the epithelial glia and axons of the outer photoreceptor cells, and a
band just beneath the retina (arrows). The retina is weakly labeled in this section. (B) Co-labeling with anti-B2 (green) shows co-localization (C) with
histamine in the band beneath the retina. Bar: 40 microns.
doi:10.1371/journal.pgen.1000245.g006
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support the idea that DVMAT-B could function as a histamine
transporter in glia. It is also conceivable that DVMAT-B could
recognize structurally related substrates such as the histamine
metabolite carcinine. Although this remains speculative, it is useful
to consider in the assessing the potential role of DVMAT-B in
histamine homeostasis.
The location of DVMAT-B and the effects of the dVMAT
mutant on histamine storage together suggest several potential
functions for DVMAT-B. First, it is possible that DVMAT-B and
the fenestrated glia play a role in histamine recycling. It is already
known that histamine released from photoreceptor cell terminals
in the lamina is metabolized to carcinine in the epithelial glia by
Ebony [44,45] and possibly transported into photoreceptor cells by
Inebriated [46]. Carcinine is then converted back into histamine in
the photoreceptors by Tan [36] to complete the recycling
pathway. The shuttle pathway involving ebony and tan is very
rapid [46]. Nonetheless, it is possible that carcinine produced by
the epithelial glia could be stored in the fenestrated glia prior to its
transport into the photoreceptor terminal, and that DVMAT-B
allows the vesicular storage of carcinine and/or histamine in the
fenestrated glia (Figure 9B, ‘‘Recycling’’ model). If DVMAT-B
allows the fenestrated glia to function as an intermediate in the
histamine-recycling pathway, it might be expected that the final
step of the pathway, conversion of carcinine to histamine in the
photoreceptors, would be blocked in dVMAT mutants. An
elevation in carcinine is seen in tan mutants, and similarly, if
DVMAT-B is required for recycling, mutation of dVMAT may
elevate carcinine contents. In future experiments we will test this
possibility using a previously developed assay [44] to analyze the
effects of ebony and tan on histamine metabolism.
Second, it is possible that the fenestrated glia play a role in
regulating the ‘spillover’ of any excess histamine that might diffuse
away from its intended site of action, or otherwise accumulate
ectopically after light-evoked release. Neurotransmitter transport-
ers play an important role in regulating the amount of transmitter
in the extracellular space that is available for signaling to
postsynaptic receptors [70–74]. Inhibition of plasma membrane
glutamate transporters, for example, increases glutamatergic
signaling at extra-synaptic ionotropic receptors in the hippocam-
pus [75] and cerebellum [76–78]. Glutamate spillover also
regulates the activation of metabotropic receptors that localize to
extrasynaptic sites on postsynaptic cells [79] and nearby neurons
[80]. Similarly, GABA and dopamine transporters may regulate
the amount of cross-talk that occurs between nearby synapses [81–
83]. The position of the epithelial glia at the site of histamine
release suggests that these rather than the fenestrated glia might
control spillover into an adjacent synapse. In addition, the
epithelial glia have recently been shown to express a histamine
receptor, HclB (HisCl1) [84,85] that could conceivably regulate
histamine storage. However, it also remains possible that the
fenestrated glia are involved in regulating possible spillover into
more distal sites or over a longer time course. If this is indeed their
primary role, loss of DVMAT-B activity would be predicted to
cause a progressive, light-evoked decrease in spatial resolution
Figure 7. dVMAT mutants show decreased histamine labeling in subretinal glia. (A–G) Confocal projection images of whole-mount
preparations of retina and optic lobes in control w (A–D) and mutant dVMATD14 homozygotes (E–G). Tangential views are shown in (A,C,D,F,G); the
surface of the lamina is shown in (B) and (E). In w tissues, a primary antiserum to histamine shows labeling of the retina (A) (arrowheads), the distal
lamina (arrows) and nerve terminals in the medulla (asterisks). dVMATD14 mutants (E–G) show reduced labeling at the surface of the lamina (E)
(arrows) and retina (F) (arrowheads) relative to the lamina (B) and retina (C) in w. Labeling of nerve terminals in the medulla (D,G) (asterisks) and an
area near the optic chiasm (D,G) (small arrow) in the dVMAT mutant (G) is less prominently reduced relative to the w control (D). (H) Cryostat sections
of a w head labeled with the anti-histamine antibody also show labeling of the lamina, including a band just beneath the retina (H) (large arrows) as
well as processes in the medulla (asterisks). Note that labeling of the retina is less evident in these cryostat sections compared with that in the
confocal stacks shown in (A–G). (I) dVMATD14 shows a decrease in labeling in the distal lamina relative to w—compare (H) and (I) (large arrows).
Labeling in the medulla (asterisks) is less reduced in dVMATD14 and is strong in the proximal lamina (small arrow). Bars: (A) 50 microns, (B–G)
25 microns, (H,I) 50 microns.
doi:10.1371/journal.pgen.1000245.g007
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through the excitation of neighboring cartridges, a possibility that
optomotor turning responses at different light intensities [86] could
reveal.
A third, recently described role for neurotransmitter transport-
ers in glia is the storage and regulated release of transmitter. In
addition to their well-established role in neurons, VGLUTs are
also expressed in glia, and exocytotic glutamate release from
astrocytes may regulate synaptic transmission [87–89]. Glial
transporters also regulate extracellular levels of neurotransmitter
through non-exocytotic mechanisms [90,91]. In mammals,
variations in the electrochemical potential across the plasma
membrane of non-neuronal cells can promote GABA efflux
through the GABA transporter [90]. A related transporter
expressed in glia, xCT, uses an exchange mechanism to regulate
glutamate levels at the Drosophila neuromuscular junction [91].
These studies highlight the emerging appreciation for glia as
important sites of neurotransmitter release.
To assess the possibility that the function of the fenestrated glia
may lie in this third role, to store and release histamine, it is useful
to consider the unusual electrophysiological properties of the
photoreceptor synapse. Since histamine activates a hyperpolariz-
ing chloride channel [33], decreased histaminergic signaling
depolarizes the target neurons in the lamina [9,92]. Therefore,
unlike most other synapses, the continuous presence of neuro-
transmitter in the synaptic cleft generates the resting state of the
postsynaptic neuron, and decreases in cleft transmitter concentra-
tion depolarize the target neurons [9]. Thus, the constant presence
of histamine in the synaptic cleft is required to maintain the
postsynaptic target neurons in their normal state. We speculate
that the fenestrated glia may provide a reserve pool of histamine
for signaling in the lamina (Figure 9B, ‘‘Reserve’’), with DVMAT-
B serving to store and/or release the reserve pool. We would
expect such release to occur under conditions of low neuronal
histamine release, as when neuronal stores have by some means
been depleted. A possible phenotype of the dVMAT mutant would
be a reduced sensitivity, or altered rate of adaptation to light,
testable using electroretinograms that report on neurotransmission
at the photoreceptor synapse [93], or more direct intracellular
recordings [94]. If glial histamine release facilitates adaptation, the
response of the mutant would be expected to differ from wt under
conditions of varying stimulus intensity. Regardless of whether the
fenestrated glia provide a substrate for histamine recycling,
spillover or reserve, further work will be required to resolve the
relationships of these cells to histamine recycling in the epithelial
glia [36,37,44,45].
For each of the models we describe, it is possible that DVMAT-
B functions in a manner similar to other vesicular transporters and
mediates the storage of histamine in intracellular vesicles, albeit in
glial rather than neuronal vesicles. Histamine could conceivably be
stored in vesicles similar to those found in mammalian glia that
release glutamate [87–89]. Alternatively, it is possible that
DVMAT-B does not function as a classical vesicular transporter.
The C-terminus of DVMAT-A is similar to the trafficking
domains of mammalian VMATs and VAChT, and as for other
vesicular transporters, DVMAT-A is efficiently endocytosed in vitro
[47,48]. In contrast, DVMAT-B contains a novel C-terminal
domain, and is poorly endocytosed in vitro [47]. Indeed, most
DVMAT-B appears to remain on the plasma membrane when it is
expressed in cultured S2 cells [47]. It is therefore possible that
DVMAT-B primarily localizes to the cell surface of the fenestrated
glia in vivo as it does in S2 cells in vitro. Given that the fenestrated
glia have extremely thin and highly convoluted processes,
distinguishing between these possibilities will require additional,
quantitative EM studies beyond those we report here.
If DVMAT-B localizes to plasma membrane in vivo as it does in
vitro, its mechanism of transport would differ from other known
vesicular transporters, all of which use a proton gradient to drive
active transport. During periods of sustained neuronal activity, the
extracellular milieu can acidify and the glial cytoplasm alkalinize
Figure 8. dVMAT mutant heads store less histamine than
controls. (A) Histamine content is decreased by 30% in the
homozygous dVMATP1 allele (P/P) and 47% in homozygotes of the
dVMATD14 allele (D14) compared with the control line w1118Cs10 (w; +/+).
Additional controls include a precise excision of the P in dVMATP1 (p.e.)
and dVMATP1 heterozygotes (P/+); one-way ANOVA p,0.0001, with
Bonferroni post-hoc test used to compare all data. Differences in head
histamine from w;+/+ are indicated as **, p,0.01 and ***, p,0.001. Bars
show the mean6SEM of independent trials measuring 3–4 heads/trial
of randomly mixed sexes, with the number of trials (n) indicated in the
bars. (B) Genetic rescue of dVMAT-B. All lines are in a genetic
background containing the transgene repo-Gal4/+, and the genotype
of the line used as a baseline control is dVMATP1/+; repo-Gal4/+
(indicated as ‘‘Base. P/+; Repo/+’’). In this background, histamine
content is reduced 45% by rendering the dVMATP1 allele homozygous
(dVMATP1/dVMATP1; repo-Gal4/+, indicated as ‘‘Mut. P/P; Repo/+’’.
Rescue was performed using repo-Gal4 with two separate UAS-
dVMAT-B transgenes, UAS-dVMAT-B1 and -B2, indicated as ‘‘Res.1 P/P;
Repo/B1’’ and ‘‘Res.2 P/P; Repo/B2’’, respectively. Additional controls
include dVMATP1 heterozygotes with repo-Gal4 and either UAS-dVMAT-
B1 or -B2, (indicated as ‘‘Con.1 P/+; Repo/B1’’, and ‘‘Con.2 P/+; Repo/
B2’’). One-way ANOVA (p,0.0006, with Dunnett’s multiple comparison
tests) shows that ‘‘Mut.’’ head histamine content differs from all other
lines (p,0.05: *). Bars show mean6SEM of independent trials
measuring 4 heads, of randomly mixed sexes, with the number of
trials indicated in the bars.
doi:10.1371/journal.pgen.1000245.g008
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[95–97]. The resultant, inwardly directed pH gradient could
conceivably cause a vesicular transporter at the plasma membrane
to transport neurotransmitter out of the cytoplasm and into the
extracellular space. However, substrate exchange rather than
active transport could also allow the export of histamine by
DVMAT-B. Indeed, it is tempting to speculate that histamine
stored in the fenestrated glia could be exchanged for extracellular
carcinine. This idea is particularly attractive if DVMAT-B and the
fenestrated glia serve to release histamine into the synaptic cleft as
in the ‘‘Reserve’’ model. In this scenario, elevated levels of synaptic
carcinine would directly activate the release of histamine into the
cleft by the fenestrated glia. The exchange of histamine for
carcinine would potentially serve both to maintain a baseline pool
of histamine in the synapse while simultaneously sequestering
carcinine for later recycling in photoreceptors.
Even though neurotransmitter metabolism in mammals differs
from that in insects [43,98], our results may bear on the transport
mechanisms by which histamine homeostasis is maintained in
mammals. Histamine uptake and metabolism in a variety of
mammalian cells, including glia, is well established [27–32].
However, as in invertebrates, the plasma membrane transporters
and putative recycling pathways for histamine both remain
unclear. The unsuspected localization of DVMAT-B to glia and
its role in regulating histamine levels in the fly raises the possibility
that mammals may employ similar, novel mechanisms for the
storage of histamine.
Materials and Methods
In situ Hybridization
For in situ hybridization, fly heads were mounted in Tissue-Tek
O.C.T. compound (Microm, Walldorf, Germany) and were shock-
frozen in liquid nitrogen. Sections (10 microns thick) were cut and
fixed with 4% paraformaldehyde. After acetylation and prehy-
bridization, subsequent hybridization with a digoxigenin-labeled
dVMAT-B specific RNA probe (see Figure 1A) was performed
overnight at 55uC. Specimens were blocked with normal goat
serum in Tris-buffer saline / 0.1% Triton X-100 (TBT) and then
treated with an alkaline phosphatase-coupled anti-digoxigenin
antiserum (1:1,000 dilution in TBT). NBT/BCIP color was
developed overnight.
UAS-dVMAT-B Lines
To facilitate the analysis of dVMAT-B transgenes, an hemag-
glutinin (HA) epitope tag was inserted at the identical site
previously used for dVMAT-A [47]. The HA tag does not affect
either expression or transport activity [47]. The HA-tagged
construct representing the previously described coding sequence
of dVMAT-B [47] was amplified using the polymerase chain
reaction (PCR) and inserted into the expression construct pEX-
UAS [99] to generate UAS-dVMAT-B. The sequence was verified
at the UCLA Genotyping and Sequencing Core Facility and flies
were transformed using standard methods [100] (Rainbow
Transgenics, Newbury Park, CA). To test expression, 9 lines were
crossed to the driver daughterless-gal4 (da-Gal4) and homogenates
from the progeny probed on Western blots as previously described
using a primary antibody (HA.11, Covance Research Products,
Denver, PA, USA) directed against the HA tag [40]. Two lines
showing moderate levels of expression were chosen for genetic
rescue experiments.
Antibody Production
To generate an antiserum against the N-terminus of DVMAT
shared by both the A and B splice variants (anti-N), a GST fusion
protein containing the first 120 amino acids of DVMAT was
generated. These residues represent the cytoplasmic N-terminus of
DVMAT-A and -B, which precedes the first predicted transmem-
brane domain [47]. The relevant amplicon was generated using PCR
and the primers AGGTGGAATTCAATCATCGACCGATG and
ATACCCAAGCTTTCAGCGATTGGATCCCCGCCAG (in-
cluding underlined EcoRI and HindIII sites respectively) and
Figure 9. The location and possible function of the fenestrated glia. (A) Photoreceptor cells R1–R6 terminate in the lamina where they
innervate lamina target neurons. Groups of six R1–R6 terminals and lamina target neurons are organized into cartridges, the component modules of
the lamina. The diagram illustrates the relationship between the photoreceptor cell axons (red), the basement membrane (blue) separating the retina
and lamina, and the lamina target neurons (silver). Identified glial subtypes in the fly’s lamina include the fenestrated (dark green), pseudocartridge
(orange), satellite (light green), epithelial (yellow), and marginal glia (brown). (B) Possible functions of DVMAT-B in the fenestrated glia include:
recycling metabolized histamine back to the photoreceptors (‘‘Recycling’’); preventing spillover of histamine into nearby cartridges (‘‘Spillover’’); and
releasing a reserve pool of histamine into the lamina to regulate its concentration during periods of heavy release (‘‘Reserve’’).
doi:10.1371/journal.pgen.1000245.g009
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subcloned between the EcoRI and HindIII sites in the expression
vector pGEX-KG, a gift of Greg Payne (UCLA), to generate a fusion
with glutathione-S transferase (GST). The fusion protein was injected
into rabbits (Cocalico Biologicals, Reamstown, PA, USA) and the
antiserum affinity purified against the same fusion protein immobi-
lized on nitrocellulose [47]. For Western blots and immunolabeling,
anti-N was used at concentrations of 1/1000 and 1/250 respectively.
To generate an antiserum specific for DVMAT-B, an HPLC-
purified peptide representing the last 21 amino acids of DVMAT-
B (SVPDSDAEAGRTNEAYESERL, B1-peptide) was synthe-
sized, conjugated to KLH and then injected into rats (Covance
Research Products). The serum was affinity purified against the
predicted carboxy terminus of DVMAT-B using a fusion protein
GST-DVMAT-B containing the DVMAT-B specific carboxy
terminal domain [47] immobilized on nitrocellulose. The affinity-
purified antibody was used at dilutions of 1:50 for immunohisto-
chemistry.
A second antibody to DVMAT-B (anti-B2) was also raised in rats.
The HPLC-purified peptide (H2N-GASVPDSDAEAGRTN+C-
CONH2, B2-peptide) was coupled to KLH and injected into rats
(Eurogentec, Seraing, Belgium). The serum was affinity purified
using B2-peptide conjugated to ACH-Sepharose. It was applied at a
dilution of 1:100 for immunohistochemistry.
dVMAT Mutants
A fly line containing a P element insertion into the gene CG6119
(the 39 end of dVMAT) [47] has been previously isolated as an
anonymous lethal gene on the second chromosome (l(2)SHO459)
[57]. The line was a generous gift of Dr. S.X. Hou (NIH) and is
maintained by the Indiana Stock Center (Bloomington, IL, USA)
as a lethal mutation balanced over CyO. We designate this allele
dVMATP1. To generate imprecise excisions from dVMATP1, the
parent line was mated to a source of transposase (D2-3) and
transposition allowed to occur in gametes of the F1 generation
using standard genetic techniques. PCR amplification using a
series of primers in the dVMAT gene was used to determine the
approximate size of any deletions that occurred. PCR products
from lines of interest were obtained from homozygous flies and
sequenced (UCLA Genotyping and Sequencing Core). For the
D14 line, a 51 base-pair sequence from the P element was
retained. This allele is designated as dVMATD14. Since dVMATD14
is phenotypically white, visual pigments that can impair immuno-
labeling experiments are absent. Another line showing a precise
excision (D10) was used as a control and is indicated in the text as
‘‘p.e.’’. Additional controls include Canton-S, and w1118 out-
crossed 10 times to Canton-S (w1118Cs10, indicated in the text as w;
+/+) [101]. dVMATP1 was outcrossed 5 times to w1118Cs10 prior to
genetic rescue experiments.
Immunofluorescent Labeling
To immunolabel histamine in whole mounts, adult heads were
manually dissected and fixed on ice in 4% 1-ethyl-3-(3-
dimethylamino-propyl)carbodiimide (EDAC), 0.1 M Na2HPO4/
NaH2PO4 buffer, pH 7.4 for 2.5 hours. For immunolabeling
experiments using anti-DVMAT-B1 heads were dissected and
fixed for 1.5 hour at 23uC in 4% PFA, 0.1 M Na2HPO4/
NaH2PO4 buffer, pH 7.4. Fixed brains were washed in PBS, 0.2%
Triton X-100, incubated for 30 minutes in PBS, 0.2% Triton X-
100, 5% FBS (block) and in 1:100 rabbit anti-histamine or 1:50 rat
anti-DVMAT-B1 antibody overnight at 4uC followed by the
corresponding secondary antibodies (1:1000 of anti-rabbit Alexa
Fluor 555, anti-rat Alexa Fluor 555, Molecular Probes, Eugene,
OR, USA) for 4 hours at 23uC before mounting in Aqua
PolyMount (Polysciences, Warrington, PA, USA).
To immunolabel cryostat sections using anti-N, heads were
fixed in 4% PFA and embedded in OCT freezing solution (Sakura
Finetechnical Co., Tokyo, Japan), frozen in liquid nitrogen and
sections cut in a frontal plane at 10 mm thickness on a cryostat
(Reichert-Jung 2800, Frigocut). The sections were processed for
double-immunolabeling with two primary antibodies, mouse anti-
Repo used at a dilution of 1:10 and rabbit anti-DVMAT N-
terminal at 1:250. The corresponding secondary antibodies were
used: Alexa-488 goat anti-mouse (Molecular Probes) at 1:100 and
Cy3 conjugated goat anti-rabbit (Jackson ImmunoResearch, West
Grove, PA) at 1:400. Labeled sections were mounted in
Vectashield beneath no. 0 cover glasses.
The anti-DVMAT-B2 antiserum (1:100), an affinity-purified
rabbit antiserum ap63 against Tan peptides (1:1000) [37], and a
rabbit anti-Ebony antiserum against a 221-aa peptide spanning
amino acids Gly438 to Asp658 of the Ebony protein [45] (1:750)
were employed for additional co-localization experiments. Primary
antisera were applied overnight at 4uC. Secondary Cy2-, Cy3- or
Cy5- conjugated antibodies (Dianova, Hamburg, Germany) were
incubated either for 2 hours at 23uC or overnight at 4uC at a
dilution of 1:200 to 1:1000. Slices were mounted in DakoCytoma-
tion Glycergel (DakoCytomation, Hamburg, Germany). For
double-labeling with anti-histamine and anti-DVMAT-B2, a
modified fixation procedure was applied: flies were fixed in 4%
2-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC) in
0.1 M phosphate buffer, pH 7.4, for 2 hours followed by 4%
paraformaldehyde for 3 hours at 4uC. Fly heads were embedded
in Tissue-Tec (Sakura Finetec, Zoeterwude, Netherlands), frozen
in liquid nitrogen and sectioned at 10 mm. Histamine was detected
with a rabbit anti-histamine antiserum (ImmunoStar, Hudson,
WI, USA) at a 1:500 dilution. Primary antisera were applied
overnight at 4uC. Secondary antibodies were incubated for
2 hours at 23uC.
EM Immunocytochemistry
Pre-embedding method. Heads were fixed in 2% PFA and
3.75% acrolein in 0.1 M PB, embedded in 7% agarose and 80 mm
slices cut in a horizontal plane using a Vibratome. The sections
were processed for immunohistochemistry with the rabbit
polyclonal anti-N-terminal epitope of DVMAT (anti-N) used at
a dilution of 1:25. A goat anti-rabbit 1.4 nm gold-conjugated
secondary antibody (Nanoprobes, Yaphank, NY, USA; Cat.
no. 2003) was used at 1:100. Labeled slices were postfixed with
2% glutaraldehyde, silver enhanced using an Amersham kit (Cat.
no. RPN491; Amersham, Bucks, UK), then postfixed with 0.5%
osmium tetroxide. After dehydration and embedding in PolyBed
810, 70 nm ultrathin sections were contrasted with uranyl acetate
and Reynold’s lead citrate and examined using an FEI Tecnai 12
electron microscope operated at 80 kV, and images collected with
a Kodak Megaview II digital camera using AnalySIS software (SIS
GmbH; Mu¨nster, Germany).
High-Performance Liquid Chromatography (HPLC)
The histamine content of adult heads was analyzed by HPLC
with fluorometric detection. Heads were homogenized and lysates
prepared as described [40]. Histamine in the head lysates was
derivatized with o-phthalaldehyde (OPA) before automated
injection onto the HPLC column. The OPA derivatizing agent
was prepared by adding 40 microliters of OPA (100 mg/ml of
ethanol) and 5 microliters of beta-mercaptoethanol to 3.95 ml of
0.125 M boric acid buffer, pH 10. A 30-microliter aliquot of OPA
reagent was reacted with the sample for 30 s. The OPA-amino
acid adducts were resolved on a reverse-phase 36150 mm column
(Betabasic-18, 3 microns, C18, Thermo Electron) with sodium
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acetate (35 mM, pH 5.9 adjusted with glacial acetic acid), 1%
tetrahydrofuran, as aqueous solvent. The organic mobile phase
consisted of 70% acetonitrile, 15% methanol, and 15% sodium
acetate (35 mM final concentration), pH 7.65 (adjusted with
glacial acetic acid). The flow rate was 0.6 ml/min with a gradient
profile as follows: 17–32% in 12 min, 32–40% in 3.5 min. The
column was washed with a gradient of 40–100% in 0.5 min, held
at 100% for 1 min, and returned to 17% in 0.5 min. The column
was equilibrated at 17% for 6 min before injection of the next
sample. Complete analysis required 24 min. The limit of detection
was 5 fmol. This whole procedure, including data collection and
calculations, was automated using Gilson hardware and software.
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